167 related articles for article (PubMed ID: 29272853)
1. Patients with newly diagnosed cervical cancer should be screened for anal human papilloma virus and anal dysplasia: Results of a pilot study using a STELLA computer simulation and economic model.
Ehrenpreis ED; Smith DG
Papillomavirus Res; 2018 Jun; 5():38-45. PubMed ID: 29272853
[TBL] [Abstract][Full Text] [Related]
2. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
3. The role of polymerase chain reaction of high-risk human papilloma virus in the screening of high-grade squamous intraepithelial lesions in the anal mucosa of human immunodeficiency virus-positive males having sex with males.
Hidalgo-Tenorio C; Rivero-Rodriguez M; Gil-Anguita C; Esquivias J; López-Castro R; Ramírez-Taboada J; de Hierro ML; López-Ruiz MA; Martínez RJ; Llaño JP
PLoS One; 2015; 10(4):e0123590. PubMed ID: 25849412
[TBL] [Abstract][Full Text] [Related]
4. The Clinical and Economic Benefits of Co-Testing Versus Primary HPV Testing for Cervical Cancer Screening: A Modeling Analysis.
Felix JC; Lacey MJ; Miller JD; Lenhart GM; Spitzer M; Kulkarni R
J Womens Health (Larchmt); 2016 Jun; 25(6):606-16. PubMed ID: 27023044
[TBL] [Abstract][Full Text] [Related]
5. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
Latsuzbaia A; Hebette G; Fischer M; Arbyn M; Weyers S; Vielh P; Schmitt F; Mossong J
Diagn Cytopathol; 2017 May; 45(5):384-390. PubMed ID: 28247516
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance.
Kim JJ; Wright TC; Goldie SJ
JAMA; 2002 May; 287(18):2382-90. PubMed ID: 11988059
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of high-grade anal dysplasia among women with high-grade lower genital tract dysplasia or cancer: Results of a pilot study.
Fokom Domgue J; Messick C; Milbourne A; Guo M; Salcedo MP; Dahlstrom KR; Chiao EY; Deshmukh AA; Sturgis EM; Schmeler KM
Gynecol Oncol; 2019 May; 153(2):266-270. PubMed ID: 30827725
[TBL] [Abstract][Full Text] [Related]
8. Liquid-based cytology and HPV DNA testing using intra-anal specimens from HIV-negative women with and without genital HPV-induced lesions.
Eleutério J; Benício GC; Giraldo PC; Gonçalves AK; Eleutério RM; Oliveira DN; Jacyntho C
Diagn Cytopathol; 2015 May; 43(5):360-5. PubMed ID: 25421882
[TBL] [Abstract][Full Text] [Related]
9. Incidence of cervical high-grade squamous intraepithelial lesions and squamous cell carcinoma in women with high-risk human papillomavirus and normal cervical cytology: A retrospective analysis of 1858 cases stratified by age and human papillomavirus genotype.
Gu L; Hong Z; Gao H; Qiu L; Di W
Cytopathology; 2019 Jul; 30(4):419-425. PubMed ID: 31069857
[TBL] [Abstract][Full Text] [Related]
10. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Anal Cytology in Women with History of Abnormal Pap Smear, Cervical Intraepithelial Neoplasia, Cervical Cancer and High Risk HPV for Anogenital Dysplasia.
Hosseini MS; Khosravi D; Farzaneh F; Ebrahimi A; Arab M; Ashraf Ganjoie T; Jamdar F; Moridi A; Chehrazi M
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3071-3075. PubMed ID: 30485943
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus oncogene mRNA testing for the detection of anal dysplasia in HIV-positive men who have sex with men.
Silling S; Kreuter A; Hellmich M; Swoboda J; Pfister H; Wieland U
J Clin Virol; 2012 Apr; 53(4):325-31. PubMed ID: 22261122
[TBL] [Abstract][Full Text] [Related]
13. Detection of oncogenic human papillomavirus impacts anal screening guidelines in men who have sex with men.
Goldstone SE; Moshier E
Dis Colon Rectum; 2010 Aug; 53(8):1135-42. PubMed ID: 20628276
[TBL] [Abstract][Full Text] [Related]
14. Anal cytology: is there a role for reflex HPV DNA testing?
Walts AE; Thomas P; Bose S
Diagn Cytopathol; 2005 Sep; 33(3):152-6. PubMed ID: 16078257
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of human papillomavirus DNA testing in the United Kingdom, The Netherlands, France, and Italy.
Kim JJ; Wright TC; Goldie SJ
J Natl Cancer Inst; 2005 Jun; 97(12):888-95. PubMed ID: 15956650
[TBL] [Abstract][Full Text] [Related]
16. Performance of HPV DNA testing with hybrid capture 2 in triaging women with minor cervical cytologic abnormalities (ASC-US/LSIL) in Northern Thailand.
Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Suprasert P; Siriaunkgul S
Asian Pac J Cancer Prev; 2014; 15(24):10961-6. PubMed ID: 25605209
[TBL] [Abstract][Full Text] [Related]
17. Anal Cytology and Human Papillomavirus Genotyping in Women With a History of Lower Genital Tract Neoplasia Compared With Low-Risk Women.
Robison K; Cronin B; Bregar A; Luis C; DiSilvestro P; Schechter S; Pisharodi L; Raker C; Clark M
Obstet Gynecol; 2015 Dec; 126(6):1294-1300. PubMed ID: 26551180
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS).
Kulasingam SL; Kim JJ; Lawrence WF; Mandelblatt JS; Myers ER; Schiffman M; Solomon D; Goldie SJ;
J Natl Cancer Inst; 2006 Jan; 98(2):92-100. PubMed ID: 16418511
[TBL] [Abstract][Full Text] [Related]
19. Syndemic synergy of HPV and other sexually transmitted pathogens in the development of high-grade anal squamous intraepithelial lesions.
McCloskey JC; Kast WM; Flexman JP; McCallum D; French MA; Phillips M
Papillomavirus Res; 2017 Dec; 4():90-98. PubMed ID: 29179876
[TBL] [Abstract][Full Text] [Related]
20. Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia.
Simms KT; Hall M; Smith MA; Lew JB; Hughes S; Yuill S; Hammond I; Saville M; Canfell K
PLoS One; 2017; 12(1):e0163509. PubMed ID: 28095411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
